Presenter:
Dr. Quentin Bazot, Head of Innovation and Development from ABL
In this webinar, Head of Innovation and Development from ABL, Dr. Quentin Bazot, shares insights into his experience with the SamuxMP mass photometer. Watch it to learn about the impact of this technology on their AAV process development workflows, its integration into their lab, and how it has accelerated their analytical workflows. With the rising demand for gene therapies using adeno-associated virus (AAV) vectors, maintaining high production quality is more critical than ever. Watch this webinar to learn:
How mass photometry accelerates early process development
Insights from a case study by ABL, a leading CDMO in viral vector manufacturing
How mass photometry enhances GMP-regulated environments and process optimization
